从十年的免疫检查点抑制中吸取的经验教训:好的,坏的和丑的
Jacob J Adashek1, Jillian A Moran2, Dung T Le3
1Department of Oncology, The Johns Hopkins Hospital, The Sidney Kimmel Comprehensive Cancer Center1800 Orleans St, Baltimore, MD, 21287, USA. jadashek@westernu.edu.
Cancer metastasis reviews
|April 4, 2025
概括
免疫检查点抑制剂 (ICI) 可以治疗癌症,但会导致毒性和耐药性. 研究探讨了它们在癌症治疗中的好处,缺点和复杂的结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 免疫检查点抑制剂 (ICI) 是一种革命性的癌症治疗方法,灵感来自于获得诺贝尔奖的关于癌症免疫逃避机制的研究.
- 在一些晚期转移性癌症患者中,ICI已经导致持久缓解,甚至治愈.
- 尽管取得了成功,但仍然存在重大挑战,包括免疫相关的毒性和广泛的瘤耐药性.
研究的目的:
- 为癌症治疗中免疫检查点抑制剂 (ICI) 提供全面的概述.
- 讨论与ICI相关的益处,不良影响和抵抗机制.
- 探索复杂的临床进展模式和ICI反应的当前生物标志物限制.
主要方法:
- 文献综述和关于免疫检查点抑制剂 (ICI) 的当前研究的综合.
- 对临床结果的分析,包括疗效,毒性和进展模式.
- 对预测ICI反应和耐药性的现有生物标志物的评估.
主要成果:
- ICI已经改变了许多癌症的治疗方法,提供了潜在的治疗方法.
- 显著的免疫相关毒性和瘤耐药性限制了ICI的有效性.
- 不寻常的进展模式,如伪进展和超进展,使治疗评估复杂化.
- 目前的生物标志物 (微卫星不稳定性,瘤突变负担,PD-L1) 是不完美的预测反应.
结论:
- ICI代表了癌症免疫治疗的重大进步,为持久反应提供了希望.
- 解决毒性和克服耐药性对于改善ICI治疗至关重要.
- 需要进一步研究复杂的瘤免疫相互作用,以完善患者选择和治疗策略.
相关概念视频
Tumor Immunotherapy
441
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
441
Cytotoxic T Cells-mediated Immune Response
812
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
812
Cell-mediated Immune Responses
66.5K
Overview
66.5K
T Cell Activation and Clonal Selection
609
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
609


